nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Loperamide—Tamoxifen—pancreatic cancer	0.149	0.161	CrCrCtD
Diphenidol—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.149	0.161	CrCrCtD
Diphenidol—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.149	0.161	CrCrCtD
Diphenidol—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.123	0.132	CrCrCtD
Diphenidol—Methadone—Tamoxifen—pancreatic cancer	0.103	0.111	CrCrCtD
Diphenidol—Clofedanol—Tamoxifen—pancreatic cancer	0.0887	0.0956	CrCrCtD
Diphenidol—Benzphetamine—Tamoxifen—pancreatic cancer	0.0858	0.0925	CrCrCtD
Diphenidol—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0795	0.0857	CrCrCtD
Diphenidol—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	4.92e-05	0.000679	CbGpPWpGaD
Diphenidol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.92e-05	0.000678	CbGpPWpGaD
Diphenidol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.9e-05	0.000676	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	4.89e-05	0.000675	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CNR1—pancreatic cancer	4.88e-05	0.000674	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	4.87e-05	0.000671	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	4.85e-05	0.000669	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRP1—pancreatic cancer	4.85e-05	0.000669	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	4.84e-05	0.000667	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	4.84e-05	0.000667	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	4.82e-05	0.000665	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GLP1R—pancreatic cancer	4.79e-05	0.000661	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	4.79e-05	0.000661	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	4.79e-05	0.000661	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—GCG—pancreatic cancer	4.72e-05	0.000651	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—DPYD—pancreatic cancer	4.72e-05	0.00065	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	4.7e-05	0.000648	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HEY2—pancreatic cancer	4.67e-05	0.000644	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	4.66e-05	0.000642	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	4.66e-05	0.000642	CbGpPWpGaD
Diphenidol—CHRM1—Circadian rythm related genes—TP53—pancreatic cancer	4.62e-05	0.000636	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	4.61e-05	0.000636	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GAST—pancreatic cancer	4.56e-05	0.000629	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GAST—pancreatic cancer	4.55e-05	0.000627	CbGpPWpGaD
Diphenidol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.52e-05	0.000623	CbGpPWpGaD
Diphenidol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.51e-05	0.000621	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GAST—pancreatic cancer	4.5e-05	0.000621	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AGTR1—pancreatic cancer	4.5e-05	0.000621	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	4.49e-05	0.000619	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SLC2A2—pancreatic cancer	4.47e-05	0.000617	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	4.44e-05	0.000613	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SCT—pancreatic cancer	4.32e-05	0.000596	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HEY1—pancreatic cancer	4.32e-05	0.000596	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SCT—pancreatic cancer	4.31e-05	0.000594	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	4.31e-05	0.000594	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SCT—pancreatic cancer	4.27e-05	0.000589	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	4.27e-05	0.000589	CbGpPWpGaD
Diphenidol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.18e-05	0.000577	CbGpPWpGaD
Diphenidol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.17e-05	0.000575	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCK—pancreatic cancer	4.13e-05	0.000569	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCK—pancreatic cancer	4.11e-05	0.000567	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCK—pancreatic cancer	4.07e-05	0.000562	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CNR2—pancreatic cancer	4.02e-05	0.000554	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GLP1R—pancreatic cancer	4.02e-05	0.000554	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—CXCL8—pancreatic cancer	4.02e-05	0.000554	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	4.01e-05	0.000553	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	4.01e-05	0.000553	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	4.01e-05	0.000552	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	3.97e-05	0.000547	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	3.97e-05	0.000547	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	3.97e-05	0.000547	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	3.96e-05	0.000545	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	3.94e-05	0.000544	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	3.9e-05	0.000538	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	3.84e-05	0.000529	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	3.82e-05	0.000527	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	3.79e-05	0.000522	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	3.78e-05	0.000521	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	3.77e-05	0.00052	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	3.73e-05	0.000515	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SHH—pancreatic cancer	3.61e-05	0.000497	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SHH—pancreatic cancer	3.59e-05	0.000496	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	3.58e-05	0.000494	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	3.57e-05	0.000493	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	3.56e-05	0.000491	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SHH—pancreatic cancer	3.56e-05	0.000491	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	3.55e-05	0.00049	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	3.54e-05	0.000488	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	3.52e-05	0.000485	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CD44—pancreatic cancer	3.47e-05	0.000478	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	3.42e-05	0.000471	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	3.42e-05	0.000471	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	3.41e-05	0.00047	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	3.41e-05	0.00047	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	3.37e-05	0.000465	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	3.37e-05	0.000465	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GCG—pancreatic cancer	3.32e-05	0.000458	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SST—pancreatic cancer	3.13e-05	0.000431	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—STK11—pancreatic cancer	3.12e-05	0.000431	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SST—pancreatic cancer	3.12e-05	0.00043	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SST—pancreatic cancer	3.09e-05	0.000426	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.08e-05	0.000425	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.07e-05	0.000424	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	3.06e-05	0.000422	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	3.05e-05	0.000421	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	3.05e-05	0.00042	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.04e-05	0.00042	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	3.04e-05	0.000419	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	3.02e-05	0.000417	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	3.01e-05	0.000415	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	2.89e-05	0.000398	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	2.88e-05	0.000397	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	2.85e-05	0.000393	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.8e-05	0.000386	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	2.79e-05	0.000385	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GCG—pancreatic cancer	2.79e-05	0.000384	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GCG—pancreatic cancer	2.78e-05	0.000383	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.76e-05	0.000381	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GCG—pancreatic cancer	2.75e-05	0.000379	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.71e-05	0.000374	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.7e-05	0.000373	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—TYMS—pancreatic cancer	2.69e-05	0.000371	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.68e-05	0.000369	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.66e-05	0.000367	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	2.65e-05	0.000365	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	2.62e-05	0.000362	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STK11—pancreatic cancer	2.62e-05	0.000361	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STK11—pancreatic cancer	2.61e-05	0.00036	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STK11—pancreatic cancer	2.59e-05	0.000357	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.46e-05	0.000339	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	2.45e-05	0.000338	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.43e-05	0.000335	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.36e-05	0.000326	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.36e-05	0.000325	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.33e-05	0.000322	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.29e-05	0.000316	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	2.29e-05	0.000315	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.27e-05	0.000313	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	2.27e-05	0.000312	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	2.26e-05	0.000312	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.24e-05	0.000309	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HES1—pancreatic cancer	2.24e-05	0.000309	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HES1—pancreatic cancer	2.23e-05	0.000308	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HES1—pancreatic cancer	2.21e-05	0.000305	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—APOE—pancreatic cancer	2.19e-05	0.000301	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.15e-05	0.000296	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	2.14e-05	0.000295	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.12e-05	0.000292	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.06e-05	0.000284	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	2.06e-05	0.000283	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	2.04e-05	0.000281	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CG—pancreatic cancer	1.97e-05	0.000272	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TERT—pancreatic cancer	1.96e-05	0.000271	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TERT—pancreatic cancer	1.96e-05	0.00027	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.94e-05	0.000267	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARG—pancreatic cancer	1.9e-05	0.000262	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.88e-05	0.000259	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	1.87e-05	0.000258	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	1.87e-05	0.000258	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	1.87e-05	0.000257	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.85e-05	0.000256	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.85e-05	0.000255	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APOE—pancreatic cancer	1.83e-05	0.000253	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APOE—pancreatic cancer	1.83e-05	0.000252	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.81e-05	0.00025	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KDR—pancreatic cancer	1.8e-05	0.000248	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KDR—pancreatic cancer	1.79e-05	0.000247	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.77e-05	0.000244	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CD—pancreatic cancer	1.73e-05	0.000239	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.71e-05	0.000236	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	1.7e-05	0.000235	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.69e-05	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	1.69e-05	0.000233	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.69e-05	0.000233	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.67e-05	0.00023	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.65e-05	0.000228	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.65e-05	0.000228	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	1.65e-05	0.000227	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	1.65e-05	0.000227	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.64e-05	0.000225	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.63e-05	0.000225	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.63e-05	0.000225	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.63e-05	0.000225	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.61e-05	0.000223	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.51e-05	0.000208	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.51e-05	0.000208	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.5e-05	0.000207	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.5e-05	0.000206	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.49e-05	0.000205	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.45e-05	0.000201	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.45e-05	0.0002	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.44e-05	0.000199	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.44e-05	0.000198	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.44e-05	0.000198	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.42e-05	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.42e-05	0.000196	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.42e-05	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.41e-05	0.000194	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	0.00018	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTEN—pancreatic cancer	1.31e-05	0.00018	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.3e-05	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.29e-05	0.000178	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	0.000175	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	1.26e-05	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.25e-05	0.000173	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	0.000168	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	1.21e-05	0.000167	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.21e-05	0.000167	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	1.21e-05	0.000166	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.2e-05	0.000166	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.19e-05	0.000165	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	0.000162	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	1.17e-05	0.000162	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	1.16e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	1.16e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	1.15e-05	0.000159	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	1.13e-05	0.000156	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	1.13e-05	0.000156	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.12e-05	0.000155	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	1.12e-05	0.000154	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.12e-05	0.000154	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.11e-05	0.000153	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.1e-05	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.1e-05	0.000151	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	0.000151	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.09e-05	0.000151	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.09e-05	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.08e-05	0.000149	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	0.000147	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	0.000147	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.05e-05	0.000145	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.01e-05	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1e-05	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	9.89e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	9.86e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	9.8e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	9.77e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	9.77e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	9.77e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	9.74e-06	0.000134	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	9.67e-06	0.000133	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	9.65e-06	0.000133	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CA—pancreatic cancer	9.21e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MYC—pancreatic cancer	9.1e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.08e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MYC—pancreatic cancer	9.07e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	9.05e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MYC—pancreatic cancer	8.99e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	8.96e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	8.9e-06	0.000123	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	8.88e-06	0.000122	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	8.79e-06	0.000121	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	8.41e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	8.38e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	8.3e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	7.73e-06	0.000107	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	7.7e-06	0.000106	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	7.63e-06	0.000105	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—pancreatic cancer	7.53e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TP53—pancreatic cancer	7.48e-06	0.000103	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TP53—pancreatic cancer	7.45e-06	0.000103	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TP53—pancreatic cancer	7.38e-06	0.000102	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	7.15e-06	9.86e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	7.13e-06	9.83e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	7.06e-06	9.73e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	6.31e-06	8.71e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	6.29e-06	8.68e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	6.23e-06	8.59e-05	CbGpPWpGaD
